![Rituximab therapy in nephrotic syndrome: implications for patients' management | Nature Reviews Nephrology Rituximab therapy in nephrotic syndrome: implications for patients' management | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrneph.2012.289/MediaObjects/41581_2013_Article_BFnrneph2012289_Fig1_HTML.jpg)
Rituximab therapy in nephrotic syndrome: implications for patients' management | Nature Reviews Nephrology
![Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fcc11304/MediaObjects/13054_2012_Article_703_Fig1_HTML.jpg)
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
![Schematic illustration of the mechanism of action of rituximab. The... | Download Scientific Diagram Schematic illustration of the mechanism of action of rituximab. The... | Download Scientific Diagram](https://www.researchgate.net/profile/Gaurang-Shah-7/publication/44578445/figure/fig1/AS:314988561485824@1452110533758/Schematic-illustration-of-the-mechanism-of-action-of-rituximab-The-antibody-labels-B.png)
Schematic illustration of the mechanism of action of rituximab. The... | Download Scientific Diagram
![Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-017-0612-x/MediaObjects/12325_2017_612_Fig1_HTML.gif)
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
![Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy | Oncology Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy | Oncology](https://www.frontiersin.org/files/Articles/359740/fonc-08-00163-HTML/image_m/fonc-08-00163-g004.jpg)
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy | Oncology
![Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncprheum0424/MediaObjects/41584_2007_Article_BFncprheum0424_Fig2_HTML.jpg)
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
![Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fncprheum0424/MediaObjects/41584_2007_Article_BFncprheum0424_Fig1_HTML.jpg)